Anti-mastitis polyvalent vaccine, method of administration and m

Details Anti-mastitis polyvalent vaccine, method of administration and m Anti-mastitis polyvalent vaccine, method of administration and m

1983-08-31

1988-08-09

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

435253, A61K 3902, C12N 120

Patent

active

047627123

ABSTRACT:
A process for the production of a polyvalent vaccine effective in the prevention and treatment of mastitis in bovine animals is disclosed, which comprises periodically culturing the milk of animals exhibiting preclinical mastitis to cultivate any pathogens present therein, killing those pathogens and incorporating each strain of cultivated, killed pathogen in a pharmacological carrier together with all other strains previously identified. The process is repeated to ensure all newly appearing pathogenic strains are vaccinated against. The vaccine so produced has been demonstated to be effective in reversal of hard udder syndrome.

REFERENCES:
patent: 3917818 (1975-11-01), Botes
patent: 4197290 (1980-04-01), Yoshida
patent: 4327082 (1982-04-01), Armitage
patent: 4425330 (1984-01-01), Norcross et al.

Affiliated with

Also associated with

Rating

Anti-mastitis polyvalent vaccine, method of administration and m does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-mastitis polyvalent vaccine, method of administration and m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-mastitis polyvalent vaccine, method of administration and m will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-917970